A new analysis published in The Lancet Oncology reveals that the European Union contributes one-sixth of global cancer research funding, totaling €7.4 billion from 2016 to 2023. The US leads with 57% of the funding, while lower-income countries receive minimal investment. The study highlights disparities in research funding, particularly for cancer surgery and radiotherapy, and warns that US funding cuts could exacerbate these inequalities.